Deep Track Capital, LP Autolus Therapeutics PLC Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Deep Track Capital, LP holds 17,849,482 shares of AUTL stock, worth $27.8 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
17,849,482
Previous 14,218,903
25.53%
Holding current value
$27.8 Million
Previous $33.4 Million
17.2%
% of portfolio
0.97%
Previous 1.47%
Shares
7 transactions
Others Institutions Holding AUTL
# of Institutions
99Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$42.3 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$32 Million0.14% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$26 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$17.2 Million0.26% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$15.5 Million0.25% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $142M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...